Drugs / Prunella oral liquid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06423235 Comparator | Jul 2024 → Jul 2025 overdue | thyroid tumor | Xintian Pharmaceutical | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prunella oral liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06423235 ↗ |
| Known as | JiRui Prunella oral liquid | “regular dose of JiRui® Prunella oral liquid” NCT06423235 ↗ |
| Route | Oral | “Prunella oral liquid” NCT06423235 ↗ |